• Imipenem: Mechanism-Led Assay Design

  2026-08-15

  Imipenem is a semisynthetic thienamycin antibiotic with a distinctive PBP-centered mechanism. This guide translates its molecular activity into better antibacterial research assays, immune response modulation studies, and sepsis animal model interpretation.

• Nigericin for pH and Mitochondrial Assays

  2026-08-14

  Nigericin converts potassium–proton exchange into measurable changes in intracellular pH, mitochondrial behavior, and cell fate. This practical guide covers stock preparation, dose-finding, cancer-cell workflows, GSDMD-linked readouts, and carefully bounded extensions to metabolic antibiotic research.

• CSB Alkaloid Pharmacokinetics in MASH Mice

  2026-08-14

  The reference study systematically examines how MASH-like liver pathology changes the pharmacokinetics and tissue distribution of three major Corydalis saxicola Bunting total alkaloids. By combining UHPLC-MS/MS exposure profiling with transporter, microsomal metabolism, cellular uptake, and PXR-related analyses, it links disease-associated pharmacokinetic variability to altered CYP450, Oatp1b2, and P-gp activity.

• Spirocyclic POM Analogues Targeting MmpL3 in TB

  2026-08-13

  The reference study develops spirocyclic phenyl oxazole methyl analogues and identifies compound 5c as a potent inhibitor of Mycobacterium tuberculosis, including drug-susceptible and resistant clinical isolates. Its combination of phenotypic screening, spontaneous mutant generation, ADME and pharmacokinetic assessment, cytotoxicity testing, and docking provides a practical framework for advancing MmpL3-directed antitubercular chemistry.

• Busulfan and the Logic of Germline Lineage Tracing

  2026-08-13

  Busulfan is more than a DNA alkylating agent: it is a mechanistically informative perturbation for testing how tissue injury, senescence, and germline depletion reshape biological interpretation. This thought-leadership article connects Busulfan-induced damage models with new dual-recombinase evidence against postnatal neo-oogenesis in mice, while defining practical boundaries for translational research.

• MEK–ERK Control of TERT in Human Stem Cells

  2026-08-12

  The reference preprint identifies a regulatory connection between MEK1/2–ERK signaling, c-Myc:MAX, and polycomb repression of TERT in human embryonic stem cells. Its findings suggest that MAPK activity helps maintain a transcriptionally permissive TERT promoter by limiting H3K27me3 accumulation, providing a mechanistic framework for studying telomere maintenance in pluripotent cells.

• MLN4924: NEDD8-Activating Enzyme Inhibitor

  2026-08-12

  MLN4924 is a potent NEDD8-activating enzyme inhibitor with a reported biochemical IC50 of 4 nM. By blocking NAE-dependent neddylation, it suppresses cullin-RING ligase activity, alters CRL-substrate turnover, and supports cancer biology research in cellular and xenograft models.

• Penicillin G Sodium: Workflow & Troubleshooting

  2026-08-11

  Turn Penicillin G Sodium into a reproducible tool for susceptibility testing, time-kill studies, and infection-model design. This guide combines cell-wall pharmacology, stability-aware handling, and lessons from an intestinal-barrier study to help separate antibacterial activity from host-response effects.

• Faropenem Sodium: From Penem Biology to AMR Strategy

  2026-08-11

  Faropenem sodium offers translational researchers a useful model for connecting PBP-driven cell wall inhibition, transporter biology, antimicrobial spectrum, and stewardship-aware resistance research. This article moves beyond a conventional product description to outline how mechanistic and experimental context should shape study design and interpretation.

• Spirocyclic POM Analogues as MmpL3 Inhibitors

  2026-08-10

  This 2024 Bioorganic Chemistry study develops spirocyclic phenyl oxazole methyl (POM) analogues as anti-tubercular compounds and identifies MmpL3 as the likely target of lead compound 5c. The lead showed activity against drug-susceptible and resistant Mycobacterium tuberculosis isolates, together with favorable early ADME, pharmacokinetic, and cytotoxicity results.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-08-09

  The reference study identifies SmD2 acetylation as a regulatory link between core spliceosome activity, BRCA1/FANC cassette-exon selection, and PARP inhibitor response in hepatocellular carcinoma. Its findings support a preclinical strategy that combines HDAC-directed modulation with PARP inhibition to expose DNA repair vulnerabilities beyond classical BRCA mutations.

• Glycogen Colorimetric Assay Kit II for Exercise Studies

  2026-08-08

  Turn liver and skeletal-muscle samples into actionable glycogen data with an interference-conscious enzymatic workflow. The Glycogen Colorimetric Assay Kit II supports circadian exercise studies, glycogen storage disease research, and scalable metabolic profiling where reducing substances can complicate oxidase-based measurements.

• Cy3-Conjugated Secondary Antibody: Signal to Insight

  2026-08-07

  Learn how the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody converts rabbit-primary-antibody binding into interpretable fluorescence. This evidence-led guide connects Cy3 assay design with rheumatoid arthritis research, controls, storage, and quantitative imaging decisions.

• Polyploid Giant Cancer Macrophages: Biomarkers of Tumor Prog

  2026-08-07

  This study demonstrates that circulating polyploid giant cancer macrophages (CAMLs) in blood are robust indicators of disease progression and metastatic potential across multiple solid tumor types. The research provides new mechanistic insights into how these cells may initiate pre-metastatic niches, challenging prior assumptions and informing both cancer biology and inflammation research.

• NU7441 (KU-57788) DNA-PK Inhibitor: Unlocking Neuroinflammat

  2026-08-06

  Explore how NU7441 (KU-57788) DNA-PK inhibitor enables advanced DNA repair and oncology research through unique neuroinflammation models. Gain actionable strategies for bridging DNA damage response studies and neurovascular disease.

7938 records 3/530 page Previous Next 12345 下5页 Last page